Literature DB >> 24887665

Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued.

Abhishek Mathur1, Sharona B Ross, Kenneth Luberice, Tony Kurian, Michelle Vice, Paul Toomey, Alexander S Rosemurgy.   

Abstract

Negative margins are the goal with pancreaticoduodenectomy for pancreatic adenocarcinoma. Thereby, margins are assessed intraoperatively with frozen section analysis and negative margins are pursued. This study was undertaken to determine the impact of margin status with pancreaticoduodenectomy for pancreatic adenocarcinoma and the value of extending resections to achieve negative margins. The intraoperative frozen section analysis and final margins for 448 patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma were assessed and their impact on survival was determined. Median data are presented. Two hundred ninety-eight (67%) patients had negative margins (R0), an additional 110 (25%) patients had microscopically positive and macroscopically negative margins (R1), and an additional 40 (9%) patients had initially positive microscopic margins, which became negative with further resection (R1 → R0). R0 resections were more likely to have smaller tumors, earlier T grade, earlier N grade, lower American Joint Committee on Cancer stage, and less frequent extrapancreatic extension (P ≤ 0.03 for each). Survival was better with R0 resections than R1 resections (20 vs 12 months, P < 0.001); extending resections to achieve negative margins (i.e., R1 → R0) did not improve survival beyond R1 resections (14 vs 12 months, P = 0.19). Survival after pancreaticoduodenectomy is disappointing. Patients with initial negative margins do best. Positive microscopic margins reflect more aggressive tumor-specific factors and lead to abbreviated survival even with extended resections to achieve negative margins (i.e., R1 → R0). With an initial positive margin, pursuing negative margins does not improve survival and, thereby, negative margins should not be "chased."

Entities:  

Mesh:

Year:  2014        PMID: 24887665

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  12 in total

Review 1.  Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy.

Authors:  Reetesh K Pai; Rish K Pai
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

3.  Positive pancreatic neck margins-a telltale sign of complex biology.

Authors:  Elie Ghabi; Jin He
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

4.  Landmark Series: Importance of Pancreatic Resection Margins.

Authors:  Mihir M Shah; Jashodeep Datta; Nipun B Merchant; David A Kooby
Journal:  Ann Surg Oncol       Date:  2022-01-05       Impact factor: 5.344

5.  A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer.

Authors:  Olga Kantor; Mark S Talamonti; Susan J Stocker; Chi-Hsiung Wang; David J Winchester; David J Bentrem; Richard A Prinz; Marshall S Baker
Journal:  J Gastrointest Surg       Date:  2016-02       Impact factor: 3.452

6.  Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer.

Authors:  Zi Yin; Yu Zhou; Baohua Hou; Tingting Ma; Min Yu; Chuanzhao Zhang; Xin Lu; Zhixiang Jian
Journal:  J Gastrointest Surg       Date:  2018-05-18       Impact factor: 3.452

7.  Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma.

Authors:  Paul Toomey; Anthony Teta; Krishen Patel; Darrell Downs; Kenneth Luberice; Sharona Ross; Alexander S Rosemurgy
Journal:  Int J Surg Oncol (N Y)       Date:  2017-04-04

8.  Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systematic review and meta-analysis.

Authors:  Emrullah Birgin; Erik Rasbach; Patrick Téoule; Felix Rückert; Christoph Reissfelder; Nuh N Rahbari
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

9.  The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma.

Authors:  Zhiqiang Chen; Bingran Yu; Jiaping Bai; Qiong Li; Bowen Xu; Zhaoru Dong; Xuting Zhi; Tao Li
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

10.  Proposal for a structured computed tomography report in the evaluation of pancreatic neoplasms based on expert opinions.

Authors:  Paulo Gustavo Maciel Lopes; Carlos Alberto Matsumoto; Edson José Lobo; Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2018 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.